ULS vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

ULS

56.2
AI Score
VS
ULS Wins

PACS

54.1
AI Score

Investment Advisor Scores

ULS

56score
Recommendation
HOLD

PACS

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ULS PACS Winner
Revenue 1.57B 2.85B PACS
Net Income 339.00M 157.06M ULS
Net Margin 21.5% 5.5% ULS
Operating Income 288.00M 229.37M ULS
ROE 21.3% 14.1% ULS
ROA 10.9% 2.8% ULS
Total Assets 3.12B 5.66B PACS
Cash 434.00M 164.45M ULS
Debt/Equity 0.19 0.21 ULS
Current Ratio 1.42 0.91 ULS

Relative Price Performance (Last 90 Days)

ULS 1M: -13.3% · 3M: -26.7% PACS 1M: -1.3% · 3M: +17.2%

Current Technical Phase

ULS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 29

RSI (14): 28.6 · Price: $75.06

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $44.25

Fundamentals Snapshot

Metric ULS PACS
Market Cap
Forward P/E 28.9 16.3
Trailing P/E 30.7 25.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.2%
Operating Margin 0.2% 0.1%
EPS 2.48 1.71
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ULS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.